Table 1. Correlation between clinicopathologic variables and IL-10 methylation index in HCC.
| Variable | Cases (120) | ∆MI ≤0 (N=80) | ∆MI >0 (N=40) | P* |
|---|---|---|---|---|
| Gender | 0.146 | |||
| Male | 96 | 67 | 29 | |
| Female | 24 | 13 | 11 | |
| Age (y) | 0.320 | |||
| ≥50 | 85 | 59 | 26 | |
| <50 | 35 | 21 | 14 | |
| HBV history | 0.760 | |||
| Yes | 92 | 62 | 30 | |
| No | 28 | 18 | 10 | |
| Differentiation | 0.429 | |||
| G1 | 48 | 30 | 18 | |
| G2-3 | 72 | 50 | 22 | |
| Cirrhosis | 0.781 | |||
| Yes | 82 | 54 | 28 | |
| No | 38 | 26 | 12 | |
| Tobacco | 0.135 | |||
| Yes | 76 | 49 | 37 | |
| No | 44 | 31 | 13 | |
| Alcohol | 0.358 | |||
| Yes | 71 | 45 | 26 | |
| No | 49 | 35 | 14 | |
| Lymph node status | 0.417 | |||
| N0 | 42 | 26 | 16 | |
| N1 | 78 | 54 | 24 | |
| Metastasis classification | 0.001 | |||
| M0 | 53 | 27 | 26 | |
| M1 | 67 | 53 | 14 | |
| AFP (µg/L) | 0.005 | |||
| ≥30 | 82 | 63 | 19 | |
| <30 | 38 | 17 | 21 |
*, statistical significance determined by Pearson’s Chi-squared test. IL-10, interleukin-10; HCC, hepatocellular carcinoma; MI, methylation index; HBV, hepatitis B virus; AFP, α-fetoprotein.